Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Quick Heal Technologies EBITDA Margin % Related Terms
Quick Heal Technologies EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUICKHEAL vs QH, SHOP, UBER: EBITDA Margin % Comparison
For the Software - Application subindustry, Quick Heal Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quick Heal Technologies EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Quick Heal Technologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Quick Heal Technologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quick Heal Technologies (NSE:QUICKHEAL) has a EBITDA Margin % of -7.71% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Quick Heal Technologies and its competitors. According to the industry distribution chart, Quick Heal Technologies ranks #2008 out of 2825 companies in the Software industry, placing it in the top 71.1%.
Is Quick Heal Technologies' EBITDA Margin % too high?
Quick Heal Technologies' current EBITDA Margin % is -7.71%. Based on the distribution chart, Quick Heal Technologies ranks #2008 out of 2825 companies in the Software industry, which is below the industry midpoint. Overall, Quick Heal Technologies has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Quick Heal Technologies' EBITDA Margin % compare to QH and SHOP?
According to the Software industry distribution chart, Quick Heal Technologies ranks #2008 out of 2825 companies for EBITDA Margin %. This places Quick Heal Technologies in the lower half of its industry. The industry median EBITDA Margin % is 8.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.16, based on 2,825 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Quick Heal Technologies and its competitors. For the Software industry, the median EBITDA Margin % is 8.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quick Heal Technologies's current EBITDA Margin % is -7.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quick Heal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Quick Heal Technologies (NSE:QUICKHEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹294.33, compared to a current price of ₹141.62 — trading 51.9% below its estimated fair value. The current EBITDA Margin % is -7.71%. Quick Heal Technologies' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Quick Heal Technologies (NSE:QUICKHEAL), the current EBITDA Margin % is -7.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quick Heal Technologies (NSE:QUICKHEAL) Overvalued in 2026?
Based on GuruFocus' analysis, Quick Heal Technologies stock appears to be undervalued.
The current stock price of ₹141.62 is trading 51.9% below its estimated GF Value™ of ₹294.33.
GuruFocus considers Quick Heal Technologies to be Significantly Undervalued.
Key valuation signals for NSE:QUICKHEAL:
EBITDA Margin %: -7.71%
GF Value™: ₹294.33 vs. price of ₹141.62 (51.9% below fair value)
No single metric tells the full story. See the NSE:QUICKHEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Heal Technologies Ltd is an India-based IT security solutions company. It is engaged in offering software security products and solutions. The company serves clients in various industries including manufacturing, BFSI, healthcare, hospitality, educational institutions, government organizations, emerging e-commerce, and the service sector. The group reports the operating segments based on the target customer groups are; Consumer, and Enterprise and Government. It has a business presence in India and foreign countries, of which maximum revenue is derived within India. Its product range consists of Quick Heal Total Security, Quick Heal Internet Security, Quick Heal AntiVirus Pro, Quick Heal Total Security for Mac, Quick Heal PCTuner 3.0, and Guardian NetSecure.
66GF Score
Get the complete analysis for NSE:QUICKHEAL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUICKHEAL has been successfully added to your 
